Skip to content

Altamira Therapeutics, Inc.

Country not established

Devices
1

What Altamira Therapeutics, Inc. makes

Altamira Therapeutics, Inc. manufactures the Bentrio™ Allergy Blocker, a device designed to mitigate allergic reactions by targeting specific immune responses.

The company’s portfolio is regulated under FDA Class II devices and requires 510(k) clearance. The manufacturer is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • BentrioTM Allergy Blocker Ref K213114

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Altamira Therapeutics, Inc. have in the registry?

The registry currently lists 1 device for Altamira Therapeutics, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Altamira Therapeutics, Inc.'s devices?

Among its 1 most recently registered device, Altamira Therapeutics, Inc. has devices listed in FDA 510(k) (1 device).

What risk classes do Altamira Therapeutics, Inc.'s devices fall under?

Among its 1 most recently registered device, the classes recorded for Altamira Therapeutics, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Altamira Therapeutics, Inc. in the registry?

The most recently registered devices listed for Altamira Therapeutics, Inc. include BentrioTM Allergy Blocker.

Generated automatically from registry data and not verified by a human reviewer.